These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30767411)

  • 1. Dynamin-like protein 1 cleavage by calpain in Alzheimer's disease.
    Jiang S; Shao C; Tang F; Wang W; Zhu X
    Aging Cell; 2019 Jun; 18(3):e12912. PubMed ID: 30767411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.
    Gan X; Huang S; Wu L; Wang Y; Hu G; Li G; Zhang H; Yu H; Swerdlow RH; Chen JX; Yan SS
    Biochim Biophys Acta; 2014 Feb; 1842(2):220-31. PubMed ID: 24252614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons.
    Sinjoanu RC; Kleinschmidt S; Bitner RS; Brioni JD; Moeller A; Ferreira A
    Neurochem Int; 2008 Sep; 53(3-4):79-88. PubMed ID: 18590784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer's disease-like pathology in hippocampal neuronal cells via the blocking of Ca
    Park J; Won J; Yang E; Seo J; Cho J; Seong JB; Yeo HG; Kim K; Kim YG; Kim M; Jeon CY; Lim KS; Lee DS; Lee Y
    Sci Rep; 2024 Jul; 14(1):15642. PubMed ID: 38977865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
    Manczak M; Calkins MJ; Reddy PH
    Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease.
    Atherton J; Kurbatskaya K; Bondulich M; Croft CL; Garwood CJ; Chhabra R; Wray S; Jeromin A; Hanger DP; Noble W
    Aging Cell; 2014 Feb; 13(1):49-59. PubMed ID: 23919677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease.
    Cho K; Cho MH; Seo JH; Peak J; Kong KH; Yoon SY; Kim DH
    Aging Cell; 2015 Oct; 14(5):878-86. PubMed ID: 26178297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-triggered m-calpain activation evokes endoplasmic reticulum stress and neuropathogenesis in a transgenic mouse model of Alzheimer's disease.
    Wang CY; Xie JW; Wang T; Xu Y; Cai JH; Wang X; Zhao BL; An L; Wang ZY
    CNS Neurosci Ther; 2013 Oct; 19(10):820-33. PubMed ID: 23889979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.
    Wang X; Su B; Fujioka H; Zhu X
    Am J Pathol; 2008 Aug; 173(2):470-82. PubMed ID: 18599615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease.
    Yan J; Liu XH; Han MZ; Wang YM; Sun XL; Yu N; Li T; Su B; Chen ZY
    Neurobiol Aging; 2015 Jan; 36(1):211-27. PubMed ID: 25192600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.
    Veeranna ; Kaji T; Boland B; Odrljin T; Mohan P; Basavarajappa BS; Peterhoff C; Cataldo A; Rudnicki A; Amin N; Li BS; Pant HC; Hungund BL; Arancio O; Nixon RA
    Am J Pathol; 2004 Sep; 165(3):795-805. PubMed ID: 15331404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase D activation induces mitochondrial fragmentation and dysfunction in cardiomyocytes.
    Jhun BS; O-Uchi J; Adaniya SM; Mancini TJ; Cao JL; King ME; Landi AK; Ma H; Shin M; Yang D; Xu X; Yoon Y; Choudhary G; Clements RT; Mende U; Sheu SS
    J Physiol; 2018 Mar; 596(5):827-855. PubMed ID: 29313986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in vitro and in vivo.
    Nikkel AL; Martino B; Markosyan S; Brederson JD; Medeiros R; Moeller A; Bitner RS
    Neuropharmacology; 2012 Sep; 63(4):606-12. PubMed ID: 22613839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase.
    Becker B; Nazir FH; Brinkmalm G; Camporesi E; Kvartsberg H; Portelius E; Boström M; Kalm M; Höglund K; Olsson M; Zetterberg H; Blennow K
    Mol Neurodegener; 2018 Aug; 13(1):47. PubMed ID: 30157938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.
    Liang B; Duan BY; Zhou XP; Gong JX; Luo ZG
    J Biol Chem; 2010 Sep; 285(36):27737-44. PubMed ID: 20595388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.